---
figid: PMC8583788__ijms-22-11520-g002
figtitle: Disentangling Mitochondria in Alzheimer’s Disease
organisms:
- Olea europaea
- Camellia sinensis
- Ginkgo biloba
- Punica granatum
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Saimiri sciureus
- Saimiri
- Caenorhabditis elegans
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Cavia porcellus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8583788
filename: ijms-22-11520-g002.jpg
figlink: /pmc/articles/PMC8583788/figure/ijms-22-11520-f002/
number: F2
caption: Schematic representation of various factors and processes involved in the
  mechanism of neuroprotection in AD. Various therapeutic approaches and physiologic
  and extracellular signals are shown in boxes 1 and 2 that induce the activity of
  AMPK and Sirt1, respectively. Downstream changes are reflected in expression of
  PGC-1α, NRF1, NRF2, Tfam, Sirt3, etc. IDE-Met(1) metabolizes mitochondrial Aβ and
  is regulated by the PGC-1α-NRF1 pathway. As a result of the activation of the AMPK-PGC-1α-NRF1-Sirtuins
  cascade, mitochondrial biogenesis, autophagy, Aβ degradation, and metabolic regulation
  are induced, and oxidative stress is reduced. A direct delivery of therapeutic molecules
  is now achievable, owing to the nano-carriers and mitochondria-targeted antioxidants.
  All of these approaches have shown success in various clinical and preclinical studies
  and hold promise for the future.
papertitle: Disentangling Mitochondria in Alzheimer’s Disease.
reftext: Ashu Johri. Int J Mol Sci. 2021 Nov;22(21):11520.
year: '2021'
doi: 10.3390/ijms222111520
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: Alzheimer’s disease | neurodegeneration | mitochondria | antioxidants |
  PGC-1α | sirtuins
automl_pathway: 0.5657865
figid_alias: PMC8583788__F2
figtype: Figure
redirect_from: /figures/PMC8583788__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8583788__ijms-22-11520-g002.html
  '@type': Dataset
  description: Schematic representation of various factors and processes involved
    in the mechanism of neuroprotection in AD. Various therapeutic approaches and
    physiologic and extracellular signals are shown in boxes 1 and 2 that induce the
    activity of AMPK and Sirt1, respectively. Downstream changes are reflected in
    expression of PGC-1α, NRF1, NRF2, Tfam, Sirt3, etc. IDE-Met(1) metabolizes mitochondrial
    Aβ and is regulated by the PGC-1α-NRF1 pathway. As a result of the activation
    of the AMPK-PGC-1α-NRF1-Sirtuins cascade, mitochondrial biogenesis, autophagy,
    Aβ degradation, and metabolic regulation are induced, and oxidative stress is
    reduced. A direct delivery of therapeutic molecules is now achievable, owing to
    the nano-carriers and mitochondria-targeted antioxidants. All of these approaches
    have shown success in various clinical and preclinical studies and hold promise
    for the future.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - .na.character
  - Ppara
  - Ppargc1a
  - Nfe2l2
  - Nrf1
  - Nfe2l1
  - Tfam
  - mic
  - Sirt1
  - Esrra
  - Sirt3
  - Alpha-re
  - Ide
  - Dnmt1
  - Hmgcr
  - Os
  - Ass1
  - Tmprss5
  - Prkaa2
  - Ik
  - ATP8A2
  - APRT
  - MFAP1
  - ATIC
  - PPARA
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PPARGC1A
  - GABPA
  - NFE2L2
  - NRF1
  - NFE2L1
  - TFAM
  - SIRT1
  - ESRRA
  - SIRT3
  - IDE
  - GZMM
  - IK
  - DYRK3
  - ASS1
  - Low
  - ATPsynbeta
  - Atpalpha
  - Amph
  - MTA1-like
  - MtnA
  - SNF4Agamma
  - AMPKalpha
  - srl
  - pgc
  - Keap1
  - cnc
  - ewg
  - anon-92Ec
  - deg
  - red
  - trc
  - Ass
  - Is
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
---
